Anti-PDK1 + PDK2 + PDK4 antibody [EPR19727] - BSA and Azide free
- RabMAb
- Recombinant
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(0 출판물)
Rabbit Recombinant Monoclonal PDK4 antibody. Carrier free. Suitable for IP, WB and reacts with Mouse, Rat, Human, Recombinant fragment - Mouse samples.
대체 명칭 보기
PDHK4, PDK4, Pyruvate dehydrogenase kinase isoform 4, PDHK1, PDK1, Pyruvate dehydrogenase kinase isoform 1, PDH kinase 1, PDHK2, PDK2, Pyruvate dehydrogenase kinase isoform 2, PDH kinase 2, PDKII
- IP
Supplier Data
Immunoprecipitation - Anti-PDK1 + PDK2 + PDK4 antibody [EPR19727] - BSA and Azide free (AB251492)
This data was developed using ab208187, the same antibody clone in a different buffer formulation.
PDK1+PDK2+PDK4 was immunoprecipitated from 0.35 mg of Mouse skeletal muscle whole cell lysate with ab208187 at 1/40 dilution.
Western blot was performed from the immunoprecipitate using ab208187 at 1/500 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : Mouse skeletal muscle whole cell lysate 10μg (Input).
Lane 2 : ab208187 IP in Mouse skeletal muscle whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab208187 in Mouse skeletal muscle whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-PDK1 + PDK2 + PDK4 antibody [EPR19727] (<a href='/ko/products/primary-antibodies/pdk1-pdk2-pdk4-antibody-epr19727-ab208187'>ab208187</a>)
false
- WB
Supplier Data
Western blot - Anti-PDK1 + PDK2 + PDK4 antibody [EPR19727] - BSA and Azide free (AB251492)
This data was developed using ab208187, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : Lanes 1-4 : 10 seconds; Lanes 5-6 : 3 minutes; Lane 7 : 2 seconds.
All lanes:
Western blot - Anti-PDK1 + PDK2 + PDK4 antibody [EPR19727] (<a href='/ko/products/primary-antibodies/pdk1-pdk2-pdk4-antibody-epr19727-ab208187'>ab208187</a>) at 1/1000 dilution
Lane 1:
Mouse skeletal muscle lysate at 10 µg
Lane 2:
Mouse heart tissue lysate at 10 µg
Lane 3:
Mouse liver tissue lysate at 10 µg
Lane 4:
C2C12 (Mouse myoblast cell line) whole cell lysate at 10 µg
Lane 5:
HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg
Lane 6:
Human heart lysate at 10 µg
Lane 7:
Rat heart tissue lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
- WB
Supplier Data
Western blot - Anti-PDK1 + PDK2 + PDK4 antibody [EPR19727] - BSA and Azide free (AB251492)
This data was developed using ab208187, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
Mouse PDK4, PDK1 and PDK2 recombinant proteins contain aa8-412, aa1-434 and aa1-407 respectively with a His-Tag®.
All lanes:
Western blot - Anti-PDK1 + PDK2 + PDK4 antibody [EPR19727] (<a href='/ko/products/primary-antibodies/pdk1-pdk2-pdk4-antibody-epr19727-ab208187'>ab208187</a>) at 1/10000 dilution
Lane 1:
Mouse PDK4 recombinant protein at 0.01 µg
Lane 2:
Mouse PDK1 recombinant protein at 0.01 µg
Lane 3:
Mouse PDK2 recombinant protein at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 47 kDa
false
Exposure time: 1s
관련 conjugated 항체와 다양한 조성의 항체 (2)
-
Anti-PDK1 + PDK2 + PDK4 antibody [EPR19727]
-
Anti-PDK4 antibody [EPR19727] - BSA and Azide free (Capture)
Reactivity 정보
제품 세부 정보
ab251492 is the carrier-free version of ab208187.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
These kinases play key roles in controlling cellular metabolism by inhibiting the conversion of pyruvate to acetyl-CoA a critical step linking glycolysis to the tricarboxylic acid (TCA) cycle. Acting separately but in functionally similar ways to each other PDK1 PDK2 and PDK4 help regulate energy homeostasis and preserve glucose during starvation or limited oxygen supply. These kinases are also part of larger complexes and interact with the pyruvate dehydrogenase complex and molecules like NADH and acetyl-CoA that further modulate their activity.
Pathways
PDK1 PDK2 and PDK4 are integral to the metabolic pathways that control glucose metabolism and TCA cycle by modulating pyruvate dehydrogenase complex activity. These kinases interact with signaling pathways in response to hormonal and nutrient signals adapting the body's energy metabolism under varying conditions. The insulin signaling pathway and hypoxia-inducible factor (HIF) pathway significantly influence their activity. Insulin signaling decreases the activity of PDK leading to an increase in pyruvate dehydrogenase activity and therefore in glucose oxidation. Meanwhile HIF pathway activation in low oxygen conditions upregulates PDKs to promote anaerobic metabolism.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
Additional targets
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com